David A. Siegel Biote Corp. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Biote Corp. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 11,100 shares of BTMD stock, worth $66,156. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,100
Previous 30,300
63.37%
Holding current value
$66,156
Previous $226,000
73.01%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BTMD
# of Institutions
83Shares Held
17.7MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$27.1 Million13.05% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$14.5 Million5.13% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$9.57 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$8.45 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.39MShares$8.3 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $45.1M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...